Monday, May 23, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

Defense Against Malignant Synthetic Biothreat Agents

by Global Biodefense Staff
March 9, 2016
Synthetic Biology Research & Development

The U.S. Department of Homeland Security (DHS) is seeking to develop an architecture for Defense against Malignant Synthetic Biothreat Agents to address the changing biodefense landscape as a result of advances in synthetic biology.

Aside from its potential to change industries and lives usefully, synthetic biology has vastly accelerated the capability to design, develop and produce biological organisms or threat agents.

Consequently, development of a systematic, coherent architecture is sought through which the government can become aware of, understand the nature of, and respond to attacks or releases using synthetic biothreats agents.

DHS seeks an architecture that would enable an overall characterization process but that would also go beyond characterization to include understandings of other elements of biodefense, including prevention, protection, response and recovery. DHS anticipates that the proposed architecture will have multiple elements to ensure effective defense against the range of potential attack outcomes.

Interested organizations are asked to submit full proposals, assessing the potential feasibility and timelines for the development of synthetic biothreat agents, as well as the consequences of the use of such agents. Responses should also address gaps in the nation’s ability to detect, protect against, respond to, and recover from attacks with these agents.

Further details are available via Solicitation Number: HSHQDC14RB0009OBAACALL11. The response deadline is March 18, 2016.

Tags: DHSEmerging ThreatsRequest for ProposalsSynthetic Biology

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Pathogens

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
Johns Hopkins: Chemical in Leafy Greens May Slow Growth of Coronaviruses
Pathogens

Johns Hopkins: Chemical in Leafy Greens May Slow Growth of Coronaviruses

April 11, 2022
Load More

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC